N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide

C53H62N8O7 — CID 160690930

IUPACN-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide
SMILESC=CCN1CC#CCN(NC(C)=O)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)C[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)C[C@H](Cc2ccccc2)C(=O)N[C@H](C(C)=O)CCCC1
InChIInChI=1S/C53H62N8O7/c1-5-24-60-25-14-13-21-44(36(3)62)56-52(67)39(29-38-17-7-6-8-18-38)32-50(65)47(30-40-33-54-45-22-11-9-19-42(40)45)57-51(66)35(2)28-49(64)48(31-41-34-55-46-23-12-10-20-43(41)46)58-53(68)61(59-37(4)63)27-16-15-26-60/h5-12,17-20,22-23,33-35,39,44,47-48,54-55H,1,13-14,21,24-32H2,2-4H3,(H,56,67)(H,57,66)(H,58,68)(H,59,63)/t35-,39+,44+,47+,48-/m1/s1
InChIKeyWPPXDRFLMZDDMI-RAFXUJQISA-N
MW923.13 g/mol
LogP5.51
Rot. Bonds10

About N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide

N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide (PubChem CID 160690930) has the molecular formula C53H62N8O7 and a molecular weight of 923.13 g/mol. Its IUPAC name is N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide.

Molecular Properties

Compound NameN-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide
PubChem CID160690930
Molecular FormulaC53H62N8O7
Molecular Weight923.13 g/mol
Exact Mass922.47
IUPAC NameN-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide
SMILESC=CCN1CC#CCN(NC(C)=O)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)C[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)C[C@H](Cc2ccccc2)C(=O)N[C@H](C(C)=O)CCCC1
InChIInChI=1S/C53H62N8O7/c1-5-24-60-25-14-13-21-44(36(3)62)56-52(67)39(29-38-17-7-6-8-18-38)32-50(65)47(30-40-33-54-45-22-11-9-19-42(40)45)57-51(66)35(2)28-49(64)48(31-41-34-55-46-23-12-10-20-43(41)46)58-53(68)61(59-37(4)63)27-16-15-26-60/h5-12,17-20,22-23,33-35,39,44,47-48,54-55H,1,13-14,21,24-32H2,2-4H3,(H,56,67)(H,57,66)(H,58,68)(H,59,63)/t35-,39+,44+,47+,48-/m1/s1
InChIKeyWPPXDRFLMZDDMI-RAFXUJQISA-N
XLogP5.51
TPSA205.67 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms68
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500923.13
LogP ≤ 55.51
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide?
The IUPAC name of N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide (CID 160690930) is N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide.
What is the SMILES notation for N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide?
The canonical SMILES for N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide is C=CCN1CC#CCN(NC(C)=O)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)C[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)C[C@H](Cc2ccccc2)C(=O)N[C@H](C(C)=O)CCCC1.
What is the InChIKey of N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide?
The InChIKey is WPPXDRFLMZDDMI-RAFXUJQISA-N. The full InChI is InChI=1S/C53H62N8O7/c1-5-24-60-25-14-13-21-44(36(3)62)56-52(67)39(29-38-17-7-6-8-18-38)32-50(65)47(30-40-33-54-45-22-11-9-19-42(40)45)57-51(66)35(2)28-49(64)48(31-41-34-55-46-23-12-10-20-43(41)46)58-53(68)61(59-37(4)63)27-16-15-26-60/h5-12,17-20,22-23,33-35,39,44,47-48,54-55H,1,13-14,21,24-32H2,2-4H3,(H,56,67)(H,57,66)(H,58,68)(H,59,63)/t35-,39+,44+,47+,48-/m1/s1.
What are the key properties of N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide?
N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide has a molecular weight of 923.13 g/mol, XLogP of 5.51, 10 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(13S,16S,19S,22R,25R)-13-acetyl-16-benzyl-19,25-bis(1H-indol-3-ylmethyl)-22-methyl-2,15,18,21,24-pentaoxo-8-prop-2-enyl-1,3,8,14,20-pentazacyclopentacos-5-yn-3-yl]acetamide is sourced from PubChem (CID 160690930), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).